Actinomycin D


Indications and Reactions:

Role Indications Reactions
Secondary
Sarcoma 19.1%
Drug Use For Unknown Indication 18.3%
Product Used For Unknown Indication 13.1%
Sarcoma Metastatic 11.6%
Rhabdomyosarcoma 11.4%
Neoplasm Malignant 8.6%
Gestational Trophoblastic Tumour 2.8%
Nephroblastoma 2.2%
Choriocarcinoma 1.9%
Ascites 1.7%
Metastases To Lung 1.7%
Rhabdoid Tumour 1.7%
Malignant Neoplasm Nos 1.4%
Ewing's Sarcoma 1.3%
Vomiting 0.7%
Mucositis 0.6%
Chondrosarcoma 0.6%
Alveolar Rhabdomyosarcoma 0.5%
Primitive Neuroectodermal Tumour 0.5%
Bone Sarcoma 0.4%
Mucosal Inflammation 15.0%
Weight Decreased 10.2%
Myelitis Transverse 8.2%
Febrile Bone Marrow Aplasia 6.8%
Pancreatitis 5.4%
Peripheral Sensorimotor Neuropathy 5.4%
Febrile Neutropenia 4.8%
Sepsis 4.8%
Tumour Necrosis 4.8%
Vomiting 4.8%
Neuralgia 3.4%
Off Label Use 3.4%
Renal Tubular Disorder 3.4%
Staphylococcal Infection 3.4%
Gastroenteritis Bacterial 2.7%
Ingrowing Nail 2.7%
Post Procedural Complication 2.7%
Presyncope 2.7%
Toxic Epidermal Necrolysis 2.7%
Ventricular Arrhythmia 2.7%
Concomitant
Testicular Neoplasm 19.4%
Rhabdomyosarcoma 18.3%
Neoplasm Recurrence 10.8%
Testis Cancer 10.8%
Chemotherapy 7.5%
Nuclear Magnetic Resonance Imaging 6.5%
Ewing's Sarcoma 5.4%
Choriocarcinoma 3.2%
Stem Cell Transplant 3.2%
Nuclear Magnetic Resonance Imaging Brain 2.2%
Product Used For Unknown Indication 2.2%
Prophylaxis 2.2%
Anaemia 1.1%
Arthralgia 1.1%
Blood Calcium Decreased 1.1%
Blood Iron Decreased 1.1%
Catheter Related Complication 1.1%
Convulsion 1.1%
Hypertension 1.1%
Infection Prophylaxis 1.1%
Acute Myeloid Leukaemia 16.7%
Febrile Neutropenia 11.1%
Interstitial Lung Disease 11.1%
Blood Pressure Inadequately Controlled 5.6%
Hemiparesis 5.6%
Leukaemia 5.6%
Mucosal Inflammation 5.6%
Nephrogenic Systemic Fibrosis 5.6%
Neutropenia 5.6%
Pneumonia 5.6%
Presyncope 5.6%
Thyroid Cancer 5.6%
Wound 5.6%
Wound Dehiscence 5.6%

Drug Data